CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Clinical trial NCT01664910 · COMPLETED

Trial details

NCT number: NCT01664910
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm

Start date: 2012-10-29
Primary completion: 2023-06-28
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.